5oq8: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Structure of CHK1 12-pt. mutant complex with arylbenzamide LRRK2 inhibitor== | ==Structure of CHK1 12-pt. mutant complex with arylbenzamide LRRK2 inhibitor== | ||
<StructureSection load='5oq8' size='340' side='right' caption='[[5oq8]], [[Resolution|resolution]] 2.00Å' scene=''> | <StructureSection load='5oq8' size='340' side='right'caption='[[5oq8]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5oq8]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5OQ8 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5OQ8 FirstGlance]. <br> | <table><tr><td colspan='2'>[[5oq8]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5OQ8 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5OQ8 FirstGlance]. <br> | ||
| Line 29: | Line 29: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
[[Category: Large Structures]] | |||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
[[Category: Acheson-Dossang, P]] | [[Category: Acheson-Dossang, P]] | ||